Yeda
234 Herzl Street, Rehovot, HaMerkaz, 7610001, Israel
Overview
Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 6
Sector focus
- AgTech
- Biotechnology
- Clean Energy
- CleanTech
- Medical Device
- Nanotechnology
- Pharmaceutical
- Quantum Computing
Investment portfolio
- Sub-Q Bionics
Participated · Seed · Mar 2026
Sub-Q Bionics is developing a next-generation implantable lymphatic drainage system—described as bionic lymph node technology—intended to manage lymphedema by assisting lymphatic circulation beneath the skin. The technology is founded on scientific innovations from the Weizmann Institute of Science and Shamir Medical Center, and Yeda supported the company through its WIN venture creation platform. The company is headquartered in Stillwater, Minnesota. Its intended system aims to provide automatic fluid management and reduce symptoms such as pain, swelling, and mobility limitations for patients living with lymphedema. Sub-Q Bionics recently closed a $1.5 million pre-seed round to advance development toward pre-clinical milestones and to build regulatory and commercial plans. The company expects to open a seed round in Q2 2026.